Inhibition of IL1 beta by Canakinumab May Be Effective against Diverse Molecular Subtypes of Lung Cancer: An Exploratory Analysis of the CANTOS Trial von Wong, Connie C., Baum, Jason, Silvestro, Angela, Beste, Michael T., Bharani-Dharan, Bharani, Xu, Siyan, Wang, Ying A., Wang, Xiaoshan, Prescott, Margaret F., Krajkovich, Lynne, Dugan, Margaret, Ridker, Paul M., Martin, Anne-Marie, Svensson, Eric C.

Volltext